Accumed Intl., Inc.
United StatesFDA applicant, unverified
- Devices
- 12
What Accumed Intl., Inc. makes
Accumed Intl., Inc. manufactures microbiological susceptibility testing plates and identification systems for bacterial cultures. These include 18- and 19-24 hour susceptibility plates for various antibiotics, such as trovafloxacin, levofloxacin, and sparfloxacin, as well as Gram-positive identification plates. The company also produces the TRACCELL 2000 Slide Mapping System for bacterial strain tracking and a modified version of the EST Culture System II for mycobacterial identification.
The company’s products are regulated under FDA’s Class I and Class II device classifications, with many authorised via the 510(k) pathway. These devices are listed in the FDA’s 510(k) database. The manufacturer is based in the United States.
Catalogue
Search and filter all 12 devicesFrequently asked questions
How many devices does Accumed Intl., Inc. have in the registry?
The registry currently lists 12 devices for Accumed Intl., Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Accumed Intl., Inc.'s devices?
Among its 12 most recently registered devices, Accumed Intl., Inc. has devices listed in FDA 510(k) (12 devices).
What risk classes do Accumed Intl., Inc.'s devices fall under?
Among its 12 most recently registered devices, the classes recorded for Accumed Intl., Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Accumed Intl., Inc. in the registry?
The most recently registered devices listed for Accumed Intl., Inc. include SENSITITRE 18 HOUR SUSCEPTIBILITY PLATES, SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATES WITH TROVAFLOXACIN, GRAM POSITIVE AUTOIDENTIFICATION PLATES, SENSITITRE AP90 and TRACCELL 2000 SLIDE MAPPING SYSTEM.